SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-037367
Filing Date
2024-12-12
Accepted
2024-12-12 16:30:51
Documents
15
Period of Report
2024-12-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K eton20241211_8k.htm   iXBRL 8-K 27874
2 EXHIBIT 10.1 FORM OF PURCHASE AGREEMENT ex_756274.htm EX-10.1 72453
  Complete submission text file 0001437749-24-037367.txt   248959

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA eton-20241210.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eton-20241210_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE eton-20241210_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eton-20241210_pre.xml EX-101.PRE 11585
17 EXTRACTED XBRL INSTANCE DOCUMENT eton20241211_8k_htm.xml XML 2845
Mailing Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278
Business Address 21925 W. FIELD PARKWAY SUITE 235 DEER PARK IL 60010-7278 (847) 787-7361
Eton Pharmaceuticals, Inc. (Filer) CIK: 0001710340 (see all company filings)

IRS No.: 371858472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38738 | Film No.: 241545310
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)